| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ace1270944221b0a21788c2ba743670e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24c39e4dc286833abc38483ab3822aee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b9f5675aac6172d688306dbcbd4b163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b56e463f8ec7725cb69287547d204399
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53f89eb9f42eea9b70d6de656066c9a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1302efdc8bd817318dd775971d3bee6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4551043796876165fe4d83830cf381ac |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-0025 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00772 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
| filingDate |
2011-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c800482e9dcfcdece23c721dd4c047c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f537eba369de674b19e313051cd5d7c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39dd7a41e284b0a2013f91edf1d0d52f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c574e9d1e6323f2adeda307b01f10789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b348ae77e24ad743ed1f3afbf3d64a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2357a0093cc70a71d2fb69fe80e895ad |
| publicationDate |
2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012082486-A1 |
| titleOfInvention |
Punctal plug with drug core retention features |
| abstract |
Disclosed are lacrimal inserts (100) and their method of use for delivery of of medication to the eye. The plug includes a body portion (101) sized to pass through a lacrimal punctum and be positioned within a lacrimal canaliculus of the eyelid. The plug may contain a core (90), or reservoir, at least partially within the body portion comprising a therapeutic agent that is configured to controlled release into the eye and is configured to release medication via a designated port, valve, or orifice in the insert housing and inhibits diffusion of medication via the housing itself. The core may include retention features to ensure that it remains securely located within the lacrimal insert over its usable life. |
| priorityDate |
2010-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |